PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for gene ...
More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved PTC's ...
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States ...
PTC Industries Limited is an India-based company, which is engaged in manufacturing of precision metal components for critical applications. It is primarily engaged in the manufacturing of metal ...
Jan 10, 2026, 1:33 AM IST PTC Industries - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Jan 10, 2026, 1:19 AM IST PTC Industries - Announcement under Regulation 30 ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Get the detailed quarterly/annual income statement for PTC Therapeutics, Inc. (PTCT). Find out the revenue, expenses and profit or loss over the last fiscal year.
PTC India Financial Services Limited is an India-based infrastructure finance company. The Company provides financing solutions to the energy value chain, which includes investing in equity or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results